Ben-Chetrit, E. et al. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study. Ann. Rheum. Dis. 77, 1558–1565 (2018).
Article CAS PubMed Google Scholar
Krainer, J., Siebenhandl, S. & Weinhäusel, A. Systemic autoinflammatory diseases. J. Autoimmun. 109, 102421 (2020).
Article CAS PubMed PubMed Central Google Scholar
Manthiram, K., Zhou, Q., Aksentijevich, I. & Kastner, D. L. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat. Immunol. 18, 832–842 (2017).
Article CAS PubMed Google Scholar
Poli, M. C. et al. Human inborn errors of immunity: 2024 update on the classification from the international union of immunological societies expert committee. J. Hum. Immun. 1, e20250003 (2025).
Article PubMed PubMed Central Google Scholar
Laboratoire de génétique moléculaire de maladies rares. Panel de gènes des maladies autoinflammatoires. https://umai-montpellier.fr/doc/Panel_MAI.pdf.
Melo Gomes, S. et al. Somatic NLRP3 mosaicism in patients with ‘mutation-negative’ CAPS: insights from a single centre UK cohort. Front. Pediatr. 13, 1598748 (2025).
Article PubMed PubMed Central Google Scholar
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Aenomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
Article PubMed PubMed Central Google Scholar
Price-Kuehne, F. et al. Clinical impact of whole exome sequencing: ten years of the Great Ormond Street hospital autoinflammation centre of excellence experience. Rheumatology 65, keag046 (2026).
Similuk, M. N. et al. Clinical exome sequencing of 1000 families with complex immune phenotypes: toward comprehensive genomic evaluations. J. Allergy Clin. Immunol. 150, 947–954 (2022).
Article CAS PubMed PubMed Central Google Scholar
Vorsteveld, E. E. et al. Clinical exome sequencing data from patients with inborn errors of immunity: cohort level diagnostic yield and the benefit of systematic reanalysis. Clin. Immunol. 268, 110375 (2024).
Article CAS PubMed Google Scholar
Gudmundsson, S. et al. Variant interpretation using population databases: lessons from gnomAD. Hum. Mutat. 43, 1012–1030 (2022).
Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024).
Article CAS PubMed PubMed Central Google Scholar
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Article CAS PubMed PubMed Central Google Scholar
Tekpinar, M., David, L., Henry, T. & Carbone, A. PRESCOTT: a population aware, epistatic, and structural model accurately predicts missense effects. Genome Biol. 26, 113 (2025).
Article CAS PubMed PubMed Central Google Scholar
Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023).
Article CAS PubMed Google Scholar
McEwen, A. E., Tejura, M., Fayer, S., Starita, L. M. & Fowler, D. M. Multiplexed assays of variant effect for clinical variant interpretation. Nat. Rev. Genet. 27, 137–154(2026).
Article CAS PubMed Google Scholar
Chen, E. et al. Rates and classification of variants of uncertain significance in hereditary disease genetic testing. JAMA Netw. Open. 6, e2339571 (2023).
Article PubMed PubMed Central Google Scholar
PFMG2025 Contributors PFMG2025-integrating genomic medicine into the national healthcare system in France. Lancet Reg. Health Eur. 50, 101183.
Rehm, H. L. et al. The landscape of reported VUS in multi-gene panel and genomic testing: time for a change. Genet. Med. 25, 100947 (2023).
Article CAS PubMed PubMed Central Google Scholar
Van Gijn, M. E. et al. New workflow for classification of genetic variants’ pathogenicity applied to hereditary recurrent fevers by the international study group for systemic autoinflammatory diseases (INSAID). J. Med. Genet. 55, 530–537 (2018).
Landrum, M. J. et al. ClinVar: updates to support classifications of both germline and somatic variants. Nucleic Acids Res. 53, D1313–D1321 (2025).
Article CAS PubMed PubMed Central Google Scholar
Karczewski, K. J. et al. The ExAC browser: displaying reference data information from over 60 000 exomes. Nucleic Acids Res. 45, D840–D845 (2017).
Article CAS PubMed Google Scholar
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020).
Article CAS PubMed PubMed Central Google Scholar
Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92–100 (2024).
Article CAS PubMed Google Scholar
Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285 (2016).
Article CAS PubMed PubMed Central Google Scholar
Rapaport, F. et al. Negative selection on human genes underlying inborn errors depends on disease outcome and both the mode and mechanism of inheritance. Proc. Natl Acad. Sci. 118, e2001248118 (2021).
Article CAS PubMed PubMed Central Google Scholar
Nielsen, R. et al. A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol. 3, e170 (2005).
Article PubMed PubMed Central Google Scholar
Theodoropoulou, K. et al. Increased prevalence of NLRP3 Q703K variant among patients with autoinflammatory diseases: an international multicentric study. Front. Immunol. 11, 877 (2020).
Article CAS PubMed PubMed Central Google Scholar
Feng, S. et al. Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants. Nat. Immunol. 26, 511–523 (2025).
Article CAS PubMed PubMed Central Google Scholar
Cosson, C. et al. Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation. J. Exp. Med. 221, e20231200 (2024).
Article CAS PubMed PubMed Central Google Scholar
Shinar, Y. et al. ISSAID/EMQN best practice guidelines for the genetic diagnosis of monogenic autoinflammatory diseases in the next-generation sequencing era. Clin. Chem. 66, 525–536 (2020).
Fatumo, S. et al. A roadmap to increase diversity in genomic studies. Nat. Med. 28, 243–250 (2022).
Comments (0)